|
|
|
|
|
 |
|
|
TCG Lifesciences Limited (formerly “Chembiotek Research International”) is a leading contract research services and informatics company with operations in India, United Kingdom and the United States in the area of drug discovery and development. TCG Lifesciences offers a new paradigm of cutting edge drug discovery and development platform whereby the R&D process is seamlessly transitioned from ‘bench to bedside and back’, and laboratory data easily accessed and managed across the product development lifecycle. Its relationships with the customers and collaborators span from specific solutions and sourcing services to integrated projects across multiple domains to complete translational research programs.
- Discovery research services: Integrated end-to-end chemistry, biology and pre-clinical research solutions for discovery of new drug candidates including New Chemical Entities (NCE) and kilo scale synthesis for first-in-man material.
- Clinical research & development services: Genomics & Proteomics research and clinical trial services
- Enterprise informatics services: Innovative enterprise solutions tailored for laboratories - analytical, quality management, bio-banking and R&D.
To bring the power of experienced leadership and management expertise closer to its customers, it has organized itself into domain specific business units:
|
|
Founded in 2001, TCGLS’ global leadership position is a result of:
- Expertise in therapeutically focused and integrated discovery and services programs.
- A talented and highly experienced scientific leadership team providing global coverage in India, Europe and the US
- Over 1,000 dedicated scientists and technical personnel, including approx. 100 PhDs and MDs
- Ability to provide customized solutions and services spanning the complete pharmaceutical value chain
- Trust based relationship with over 200 customers including 15 of the top 20 global pharmaceutical companies.
- Several strategic public-private partnerships with national and international centers of excellence.
- State-of-the-art research facilities spread over 250,000 square feet with another 100,000 under construction.
- Preferred access to ‘The Centre of Genomic Applications’, one of India’s largest genomics & proteomics facilities.
|
|
| |
|
